Related Experiment Video
Updated: Mar 21, 2026

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
Epigenetics: spotlight on type 2 diabetes and obesity
A Desiderio1,2, R Spinelli1,2, M Ciccarelli1,2
1URT of the Institute of Experimental Endocrinology and Oncology "G. Salvatore", National Council of Research, Naples, Italy.
Epigenetics, specifically DNA methylation, plays a role in type 2 diabetes and obesity risk. This review explores how these epigenetic changes contribute to these widespread public health issues.
Area of Science:
- Biomedicine
- Genetics
- Epigenetics
Background:
- Type 2 diabetes (T2D) and obesity are significant global health challenges.
- Genetic factors explain only a small portion of the risk for these complex diseases.
- Epigenetics, including DNA methylation, is emerging as a key factor influencing disease susceptibility.
Purpose of the Study:
- To review the role of DNA methylation in the development of type 2 diabetes.
- To examine the contribution of DNA methylation to obesity risk.
- To highlight epigenetics as a critical area for understanding T2D and obesity.
Main Methods:
- Literature review focusing on DNA methylation studies related to T2D and obesity.
- Analysis of current research on epigenetic modifications and their impact on metabolic health.
- Synthesis of findings on the relationship between DNA methylation patterns and disease risk.
Main Results:
- DNA methylation changes are implicated in the pathophysiology of type 2 diabetes.
- Alterations in DNA methylation are associated with obesity and its metabolic consequences.
- Epigenetic mechanisms offer potential explanations for the 'missing heritability' in T2D and obesity.
Conclusions:
- DNA methylation is a crucial epigenetic mechanism contributing to type 2 diabetes and obesity.
- Understanding these epigenetic contributions is vital for advancing research and potential interventions.
- Epigenetic factors represent a promising avenue for future therapeutic strategies in metabolic diseases.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Psychoneuroimmunology: Diabetes and Cancer
Obesity

